These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Ex vivo expansion of mafosfamide-purged PBPC products. McNiece I; Civin C; Harrington J; Kellner J; Malehorn M; Turney J; Barber J; Jones R Cytotherapy; 2006; 8(5):459-64. PubMed ID: 17050250 [TBL] [Abstract][Full Text] [Related]
83. Effects of retinoic acid and amifostine on in vitro growth of normal hemopoietic progenitor cells. Arboscello E; Botta M; Romero D; Schenone E; Mencoboni M; Bogliolo G; Pannacciulli I Anticancer Res; 2001; 21(2A):1139-43. PubMed ID: 11396153 [TBL] [Abstract][Full Text] [Related]
84. Dose and interval relationship for the interaction of WR-2721 and nitrogen mustard with normal and malignant cells. Valeriote F; Grates HE Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1561-4. PubMed ID: 6090362 [TBL] [Abstract][Full Text] [Related]
85. New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation. Shpall EJ; Stemmer SM; Bearman SI; Myers S; Purdy M; Jones RB Breast Cancer Res Treat; 1993; 26 Suppl():S19-23. PubMed ID: 7691269 [TBL] [Abstract][Full Text] [Related]
86. Peripheral blood progenitor cell mobilization with Dexa-Beam/G-CSF, ether lipid purging, and autologous transplantation after high-dose CBV treatment: a safe and effective regimen in patients with poor risk malignant lymphomas. Knauf WU; Koenigsmann MP; Notter M; Hoppe B; Reufi B; Oberberg D; Thiel E; Berdel WE Leuk Lymphoma; 1996 Oct; 23(3-4):305-11. PubMed ID: 9031111 [TBL] [Abstract][Full Text] [Related]
87. Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide. Olivieri A; Poloni A; Montanari M; Cantori I; Corvatta L; Masia MC; Curzi L; Mancini S; Leoni P J Hematother; 1997 Apr; 6(2):137-44. PubMed ID: 9131443 [TBL] [Abstract][Full Text] [Related]
93. WR-1065, the active metabolite of amifostine (Ethyol), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells. Alberts DS; Speicher LA; Krutzsch M; Wymer J; Capizzi RL; Conlon J; Barrett A; Aickin M Eur J Cancer; 1996; 32A Suppl 4():S17-20. PubMed ID: 8976817 [TBL] [Abstract][Full Text] [Related]
94. Bone marrow stem cell protection from chemotherapy by low--molecular-weight compounds. Guest I; Uetrecht J Exp Hematol; 2001 Feb; 29(2):123-37. PubMed ID: 11166451 [TBL] [Abstract][Full Text] [Related]
95. Label-free neuroblastoma cell separation from hematopoietic progenitor cell products using acoustophoresis - towards cell processing of complex biological samples. Olm F; Urbansky A; Dykes JH; Laurell T; Scheding S Sci Rep; 2019 Jun; 9(1):8777. PubMed ID: 31217534 [TBL] [Abstract][Full Text] [Related]
97. A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplants. Nahimana A; Aubry D; Lagopoulos L; Greaney P; Attinger A; Demotz S; Dawson KM; Schapira M; Tschopp J; Dupuis M; Duchosal MA Blood Cancer J; 2011 Dec; 1(12):e47. PubMed ID: 22829095 [TBL] [Abstract][Full Text] [Related]
98. A novel mode of stimulating platelet formation activity in megakaryocytes with peanut skin extract. Sato T; Akiyama M; Nakahama KI; Seo S; Watanabe M; Tatsuzaki J; Morita I J Nat Med; 2018 Jan; 72(1):211-219. PubMed ID: 29019067 [TBL] [Abstract][Full Text] [Related]
99. Role of stem cells in cancer therapy and cancer stem cells: a review. Sagar J; Chaib B; Sales K; Winslet M; Seifalian A Cancer Cell Int; 2007 Jun; 7():9. PubMed ID: 17547749 [TBL] [Abstract][Full Text] [Related]
100. Ex vivo pharmacological purging of leukapheresis collections with nitrogen mustard: amifostine pretreatment improves both early and late peripheral blood progenitor cell recovery. Poloni A; Leoni P; Curzi L; Cantori I; Mancini S; Montanari M; Masia MC; Olivieri A Exp Hematol; 1999 Oct; 27(10):1548-56. PubMed ID: 10517497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]